BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2016
View Archived Issues
Phase II results demonstrate safety and efficacy of new drug for Wilson's disease
Read More
Oyi-based therapeutic HIV vaccine reduces the HIV RNA rebound median following cART interruption
Read More
TGI and Quark enter discovery and development collaboration
Read More
Zavante starts ZEUS trial for ZTI-01 in cUTI patients
Read More
KU Leuven and Ortho-McNeil-Janssen Pharmaceuticals patent dengue viral replication inhibitors
Read More
Oncolytics reports results on Reolysin phase II study
Read More
Akari and XL-protein to develop longer-acting version of Coversin
Read More
Synta Pharmaceuticals and Madrigal Pharmaceuticals announce merger agreement
Read More
RespiVert and Topivert Pharma disclose MAPK14, Src and Syk inhibitors
Read More
Redx Pharma develops IDO1 and/or TDO2 inhibitors
Read More
XuanZhu Pharma describes ALK and MCF3 inhibitors
Read More
Merrimack and Leica partner to develop companion diagnostic assays
Read More
PI3K inhibitors revealed in XuanZhu Pharma patent
Read More
Presage extends alliance with Takeda to provide access to CIVO platform
Read More
Burzynski Research Institute initiates phase II trial in diffuse intrinsic brainstem glioma
Read More
GeoVax receives SBIR grant for clade B HIV vaccine
Read More
TGen announces two new combination trials in pancreatic cancer
Read More
FDA acepts sBLA for Opdivo in patients with classical Hodgkin lymphoma
Read More
PsiOxus and Parker Institute collaborate on T-sign cancer platform
Read More
USAID launches Combating Zika and Future Threats: A Grand Challenge for Development
Read More
Phase I/IIa study investigates topically applied bisphosphocin Nu-3 for diabetic ulcers
Read More
FBRI and Meiji Seika collaborate on autoimmune and cancer drug research
Read More
Promising HCV T-cell vaccine HCV-003 to advance to phase II trials
Read More
Novel mutation in USMG5 gene may cause Leigh syndrome
Read More